Medical Devices: Page
-
Boston Scientific to acquire Penumbra for $14.5B
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
By Elise Reuter • Jan. 15, 2026 -
Medtronic inks deal to build brain computer interface into surgical system
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation system.
By Nick Paul Taylor • Jan. 15, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Deep Dive
5 topics to watch as MDUFA negotiations restart
The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.
By Elise Reuter • Jan. 14, 2026 -
Boston Scientific gains FDA’s OK for new PFA catheter
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.
By Susan Kelly • Jan. 14, 2026 -
Smith & Nephew to acquire Integrity Orthopaedics for up to $450M
The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.
By Nick Paul Taylor • Jan. 14, 2026 -
Medtronic gets FDA clearance for smart insulin pen app
The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.
By Elise Reuter • Jan. 13, 2026 -
Inspire appoints Matt Osberg as CFO
While Osberg joins Inspire without prior medtech experience, CEO Tim Herbert says the new CFO can help take the company “to the next level.”
By Nick Paul Taylor • Jan. 13, 2026 -
Boston Scientific to buy incontinence device maker Valencia
The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.
By Susan Kelly • Jan. 12, 2026 -
Edwards calls off JenaValve buyout after court halts deal
Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.
By Susan Kelly • Jan. 12, 2026 -
Haemonetics to acquire Vivasure Medical
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.
By Elise Reuter • Jan. 9, 2026 -
CMR robot earns CE mark in pediatrics; SS Innovations readies smaller instruments
CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while SS Innovations will incorporate five new instruments into its SSi Mantra system.
By Susan Kelly • Jan. 9, 2026 -
Teleflex CEO leaving company
Stuart Randle, who retired in 2018, has replaced Liam Kelly as CEO and president on an interim basis.
By Nick Paul Taylor • Jan. 9, 2026 -
FDA exempts more wearable, AI features from oversight
In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight.
By Elise Reuter • Jan. 8, 2026 -
Deep Dive
4 medtech topics to watch in 2026
From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in 2026.
By Ricky Zipp • Jan. 8, 2026 -
Surgerii Robotics raises $100M to fund global expansion
The China-based surgical robot manufacturer is gearing up for growth after receiving Europe’s CE mark last year for its single port endoscopic system.
By Susan Kelly • Jan. 7, 2026 -
J&J submits FDA de novo request for Ottava robot in general surgery
Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft tissue robotic surgery market heats up.
By Susan Kelly • Jan. 7, 2026 -
Stereotaxis wins FDA approval for robotically navigated ablation catheter
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.
By Nick Paul Taylor • Jan. 7, 2026 -
STAAR shareholders reject Alcon’s revised buyout offer
The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.
By Susan Kelly • Jan. 6, 2026 -
Vicarious inks software partnership as it streamlines operations
Under the agreement, the engineering partner will be responsible for a significant portion of the software development for the Vicarious robotic system.
By Susan Kelly • Jan. 6, 2026 -
Biobeat raises $50M to commercialize cuffless blood pressure monitor
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
By Nick Paul Taylor • Jan. 6, 2026 -
Q&A
Ōura’s Ricky Bloomfield proposes new regulatory pathway for wearable health features
The chief medical officer is interested in an easier path to market for health screening features in wearable devices.
By Elise Reuter • Jan. 5, 2026 -
New Henry Schein CEO expected by mid-January as Bergman extends tenure
Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the end of 2025.
By Nick Paul Taylor • Jan. 5, 2026 -
Edwards receives FDA approval for mitral valve replacement system
The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.
By Elise Reuter • Dec. 23, 2025 -
FDA posts Class I recall notice about Medtronic heart vent catheters
The company received three complaints about patients who had perforation injuries linked to the devices.
By Nick Paul Taylor • Dec. 23, 2025 -
Abbott receives FDA approval for Volt PFA system
Abbott can now compete with Medtronic, Boston Scientific and J&J in the U.S. for the fast-growing pulsed field ablation market.
By Elise Reuter • Dec. 22, 2025